Case File №
#VI-2026-0296
EHZ Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
35 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C Okay | 25 | 7.1 | 4.6 | 10.0 | 20 Jun 2025 |
| Tirzepatide | C Okay | 14 | 6.3 | 4.1 | 9.9 | 25 Jul 2025 |
| 4-Anilinopiperidine CAS 99918-43-1 | C Fair | 3 | 6.7 | 6.0 | 7.5 | 20 May 2026 |
| 5-amino-1MQ | C Fair | 3 | 6.3 | 5.8 | 7.3 | 24 May 2026 |
| Aromasin (Exemestane) | C Fair | 3 | 6.1 | 4.7 | 7.9 | 23 May 2026 |
| Boldenone Cypionate | C Fair | 2 | 6.7 | 6.3 | 7.0 | 21 May 2026 |
| BPC157 10mg + TB500 10mg Blend | C Fair | 3 | 6.0 | 4.8 | 7.7 | 21 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 6.6 | 6.6 | 6.6 | 3 Jun 2025 |
| Chonluten | X N/A | 1 | 6.3 | 6.3 | 6.3 | 27 Feb 2025 |
| CJC-1295 With DAC | X N/A | 1 | 5.5 | 5.5 | 5.5 | 11 Jun 2025 |
| Cortagen | C Fair | 3 | 6.5 | 4.5 | 8.8 | 19 Jan 2026 |
| DHB (1-Test Cyp) | C Fair | 2 | 6.5 | 5.9 | 7.1 | 26 Jan 2026 |
| Dianabol Raw | C Fair | 3 | 7.1 | 6.4 | 7.9 | 24 May 2026 |
| DSIP | C Fair | 2 | 8.9 | 8.5 | 9.4 | 17 May 2026 |
| EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | C Fair | 3 | 6.6 | 6.5 | 6.8 | 25 May 2026 |
| Epithalon | C Fair | 3 | 6.5 | 6.1 | 6.9 | 21 May 2026 |
| GHRP-6 Acetate | X N/A | 1 | 8.1 | 8.1 | 8.1 | 3 Jul 2025 |
| Hyaluronic acid | X N/A | 1 | 8.3 | 8.3 | 8.3 | 27 Feb 2025 |
| Ivermectin | C Fair | 3 | 6.6 | 6.2 | 7.0 | 26 Jan 2026 |
| MOTS-C | C Fair | 2 | 7.0 | 5.7 | 8.3 | 24 May 2026 |
| MT-1 | C Fair | 3 | 6.4 | 5.0 | 7.7 | 25 May 2026 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 7.5 | 7.5 | 7.5 | 2 Apr 2025 |
| Orforglipron | X N/A | 1 | 7.7 | 7.7 | 7.7 | 2 Jul 2025 |
| P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | C Fair | 3 | 6.5 | 4.7 | 9.5 | 20 May 2026 |
| PE 22-28 | C Fair | 3 | 7.5 | 5.9 | 9.5 | 17 May 2026 |
| Proviron (Mesterolone) Raw | X N/A | 1 | 9.0 | 9.0 | 9.0 | 17 Dec 2024 |
| RAD140 | C Fair | 2 | 8.1 | 7.8 | 8.3 | 23 May 2026 |
| Selank 10mg + Semax 10mg Blend | C Fair | 3 | 5.8 | 5.1 | 6.3 | 24 May 2026 |
| Semax | C Fair | 2 | 7.0 | 6.0 | 8.0 | 21 May 2026 |
| SR9009 | C Fair | 3 | 6.3 | 6.0 | 6.7 | 20 May 2026 |
| Super Shred | C Fair | 3 | 8.0 | 6.8 | 9.9 | 21 May 2026 |
| Test Enanthate | C Fair | 3 | 4.9 | 4.0 | 6.6 | 24 May 2026 |
| Thymosin Alpha-1 | C Fair | 3 | 7.9 | 7.0 | 9.4 | 25 May 2026 |
| Tirzepatide Oral | C Fair | 2 | 5.1 | 4.8 | 5.4 | 21 May 2026 |
| YK-11 Raw | X N/A | 1 | 9.0 | 9.0 | 9.0 | 2 Jul 2025 |
Exhibit II
Evidence Log
81 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | MT-1 | 5.3 B | 50mg | 52.2mg | +4.5% | 95.44% | pw5i6a | Lab D | Public |
| 24 May 2026 | DHB (1-Test Cyp) | 9.4 A | 250mg/ml | 234.6mg/ml | -6.2% | 96.87% | j7ju59 | Lab F | Public |
| 24 May 2026 | EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | 6.8 A | 500g | 525.5g | +5.1% | 98.34% | sbvlm9 | Lab E | Community |
| 24 May 2026 | MT-1 | 5.6 B | 20mg | 24.7mg | +23.5% | 95.90% | l597it | Lab G | Public |
| 24 May 2026 | PE 22-28 | 7.1 A | 30mg | 32.1mg | +7.1% | 99.58% | i0fq1p | Lab D | Public |
| 24 May 2026 | Test Enanthate | 5.6 B | 250mg/ml | 294.9mg/ml | +18.0% | 97.14% | j8l24t | Lab E | Public |
| 24 May 2026 | Retatrutide | 6.5 B | 15mg | 13.8mg | -8.0% | 99.70% | (no batch ID) | Lab G | Public |
| 24 May 2026 | Aromasin (Exemestane) | 7.1 A | 100mg | 123.2mg | +23.2% | 96.69% | 8joudd | Lab C | Community |
| 24 May 2026 | Cortagen | 6.0 A | 5mg | 4.5mg | -9.5% | 96.75% | 69wzcx | Lab E | Public |
| 24 May 2026 | Dianabol Raw | 5.3 B | 5g | 6.2g | +24.3% | 96.79% | v8klup | Lab F | Public |
| 24 May 2026 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 5.6 B | 10g | 11.5g | +14.7% | 99.12% | ygoe4o | Lab G | Public |
| 24 May 2026 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 6.6 A | 100g | 88.7g | -11.3% | 99.30% | ue0kxc | Lab A | Community |
| 24 May 2026 | 5-amino-1MQ | 5.7 B | 15mg | 18.3mg | +22.2% | 95.65% | tzka0p | Lab A | Public |
| 24 May 2026 | Cortagen | 6.4 A | 50mg | 48.7mg | -2.7% | 98.27% | hlgp2w | Lab B | Community |
| 24 May 2026 | YK-11 Raw | 9.4 A | 500g | 428.9g | -14.2% | 96.10% | ms4yva | Lab C | Community |
| 23 May 2026 | EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | 6.7 A | 1g | 1.1g | +12.7% | 96.61% | 4x05cd | Lab C | Public |
| 23 May 2026 | Hyaluronic acid | 9.0 A | 10mg | 11.7mg | +16.6% | 99.33% | waswc9 | Lab D | Public |
| 23 May 2026 | N-Acetyl Epitalon Amidate | 7.7 A | 5mg | 4.6mg | -7.5% | 95.38% | 57vlwc | Lab F | Community |
| 23 May 2026 | Semax | 5.6 B | 10mg | 9.3mg | -6.8% | 98.21% | hc140q | Lab D | Public |
| 21 May 2026 | Tirzepatide | 7.8 A | 30mg | 31.3mg | +4.3% | 99.83% | (no batch ID) | Lab E | Public |
| 21 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 7.4 A | 100g | 109.6g | +9.6% | 96.35% | dxugk8 | Lab B | Public |
| 21 May 2026 | Thymosin Alpha-1 | 10.0 A | 10mg | 10.8mg | +7.7% | 97.80% | eytsbn | Lab D | Community |
| 21 May 2026 | Aromasin (Exemestane) | 4.0 C | 50mg | 51.4mg | +2.8% | 96.52% | zq8z2z | Lab F | Public |
| 21 May 2026 | SR9009 | 5.7 B | 25mg | 24.3mg | -3.0% | 98.66% | bxq2m3 | Lab E | Public |
| 21 May 2026 | Test Enanthate | 8.1 A | 300mg/ml | 264.9mg/ml | -11.7% | 96.78% | ji25r3 | Lab A | Public |
| 20 May 2026 | Retatrutide | 9.8 A | 50mg | 49.7mg | -0.6% | 99.80% | 9/25/25 | Lab G | Public |
| 20 May 2026 | Boldenone Cypionate | 7.3 A | 200mg/ml | 214.0mg/ml | +7.0% | 99.85% | orsztm | Lab E | Public |
| 20 May 2026 | Epithalon | 5.8 B | 20mg | 18.7mg | -6.4% | 97.06% | 7z01pa | Lab E | Public |
| 20 May 2026 | GHRP-6 Acetate | 7.9 A | 2mg | 2.0mg | +1.7% | 96.99% | irjd83 | Lab A | Public |
| 19 May 2026 | Tirzepatide | 6.5 B | 60mg | 54.5mg | -9.2% | 99.80% | (no batch ID) | Lab G | Public |
| 19 May 2026 | Retatrutide | 6.3 B | 30mg | 32.9mg | +9.7% | 99.80% | (no batch ID) | Lab G | Public |
| 19 May 2026 | 5-amino-1MQ | 7.4 A | 5mg | 4.3mg | -14.2% | 96.95% | umou2e | Lab D | Community |
| 19 May 2026 | Ivermectin | 7.2 A | 10mg | 9.9mg | -0.8% | 95.54% | bnxyfx | Lab F | Community |
| 19 May 2026 | Ivermectin | 7.2 A | 25mg | 28.4mg | +13.4% | 99.85% | e41pp7 | Lab G | Public |
| 19 May 2026 | Proviron (Mesterolone) Raw | 8.9 A | 5g | 5.1g | +1.3% | 97.57% | xfk3bg | Lab C | Community |
| 19 May 2026 | Retatrutide | 7.0 A | 10mg | 10.8mg | +8.0% | 99.90% | (no batch ID) | Lab E | Public |
| 17 May 2026 | Boldenone Cypionate | 5.4 B | 200mg/ml | 190.0mg/ml | -5.0% | 96.52% | tq3zaz | Lab E | Community |
| 29 Jan 2026 | BPC157 10mg + TB500 10mg Blend | 7.5 A | 2mg | 1.9mg | -6.2% | 96.66% | uwans4 | Lab C | Community |
| 29 Jan 2026 | Thymosin Alpha-1 | 7.3 A | 10mg | 11.9mg | +19.4% | 98.89% | z6xjbl | Lab C | Public |
| 29 Jan 2026 | Thymosin Alpha-1 | 8.8 A | 10mg | 9.9mg | -1.2% | 98.53% | toy5ws | Lab C | Public |
| 26 Jan 2026 | Tirzepatide | 6.1 B | 20mg | 22.1mg | +10.5% | 99.80% | (no batch ID) | Lab G | Public |
| 26 Jan 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 8.5 A | 500g | 559.1g | +11.8% | 95.78% | yo8wpr | Lab F | Public |
| 26 Jan 2026 | Aromasin (Exemestane) | 4.9 C | 50mg | 54.0mg | +8.0% | 95.51% | l4pc47 | Lab A | Community |
| 19 Jan 2026 | MOTS-C | 5.8 B | 15mg | 13.0mg | -13.1% | 95.71% | 0u7ent | Lab D | Public |
| 9 Jan 2026 | Epithalon | 7.3 A | 20mg | 18.0mg | -10.0% | 99.48% | oyy0oh | Lab G | Community |
| 9 Jan 2026 | Epithalon | 5.8 B | 2mg | 2.2mg | +10.2% | 95.18% | jo1vld | Lab D | Public |
| 7 Jan 2026 | Dianabol Raw | 6.8 A | 1g | 1.1g | +11.9% | 98.18% | gfmevl | Lab F | Public |
| 7 Jan 2026 | DSIP | 8.8 A | 15mg | 13.7mg | -8.7% | 98.50% | c3wfa4 | Lab D | Community |
| 7 Jan 2026 | P2NP (1-phenyl-2-nitropropene) CAS 705-60-2 | 5.6 B | 500g | 495.1g | -1.0% | 97.15% | rkai7n | Lab G | Public |
| 7 Jan 2026 | SR9009 | 7.3 A | 100mg | 108.8mg | +8.8% | 99.61% | pdx5ez | Lab G | Community |
| 6 Jan 2026 | CJC-1295 With DAC | 4.7 C | 30mg | 33.7mg | +12.2% | 99.39% | z7z2q5 | Lab D | Public |
| 6 Jan 2026 | MOTS-C | 8.5 A | 5mg | 5.6mg | +12.4% | 96.54% | pno306 | Lab B | Public |
| 6 Jan 2026 | Selank 10mg + Semax 10mg Blend | 5.7 B | 20mg | 20.3mg | +1.5% | 98.74% | 21saoz | Lab C | Community |
| 6 Jan 2026 | Test Enanthate | 4.1 C | 100mg/ml | 119.2mg/ml | +19.2% | 96.23% | ic1er8 | Lab C | Public |
| 29 Dec 2025 | 4-Anilinopiperidine CAS 99918-43-1 | 6.6 A | 10g | 9.1g | -9.2% | 99.99% | gj6rfk | Lab B | Community |
| 29 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.8 B | 5mg | 4.4mg | -11.2% | 95.22% | 2zyl2o | Lab C | Public |
| 29 Dec 2025 | Semax | 7.4 A | 50mg | 49.5mg | -0.9% | 95.33% | c9ovce | Lab D | Public |
| 29 Dec 2025 | Super Shred | 7.3 A | 300mg/ml | 311.8mg/ml | +3.9% | 99.48% | q3wc33 | Lab D | Public |
| 29 Dec 2025 | Tirzepatide Oral | 7.7 A | 100mg | 85.2mg | -14.8% | 98.23% | hp7stx | Lab E | Public |
| 12 Dec 2025 | DSIP | 10.0 A | 20mg | 23.9mg | +19.4% | 96.05% | 2q87ny | Lab B | Public |
| 12 Dec 2025 | Super Shred | 7.8 A | 300mg/ml | 294.1mg/ml | -2.0% | 95.02% | 0nzgbx | Lab B | Public |
| 5 Dec 2025 | BPC157 10mg + TB500 10mg Blend | 8.6 A | 15mg | 18.3mg | +21.9% | 97.28% | tb448u | Lab G | Public |
| 5 Dec 2025 | Cortagen | 6.9 A | 50mg | 49.2mg | -1.5% | 97.96% | y029k5 | Lab A | Community |
| 23 Nov 2025 | 5-amino-1MQ | 5.7 B | 30mg | 32.8mg | +9.4% | 98.30% | 7owgt2 | Lab B | Public |
| 23 Nov 2025 | DHB (1-Test Cyp) | 6.8 A | 250mg/ml | 307.7mg/ml | +23.1% | 96.46% | 2b7w9t | Lab G | Community |
| 23 Nov 2025 | EAPA (ethyl alpha-phenylacetoacetate / ethyl 3-oxo-2-phenylbutanoate) CAS 5413-05-8 | 5.7 B | 500g | 569.7g | +13.9% | 99.31% | um09od | Lab A | Community |
| 23 Nov 2025 | Orforglipron | 7.4 A | 20mg | 17.8mg | -11.1% | 98.27% | 2rj8sd | Lab C | Community |
| 23 Nov 2025 | RAD140 | 8.1 A | 50mg | 52.6mg | +5.2% | 97.62% | ljwmfk | Lab B | Community |
| 23 Nov 2025 | Super Shred | 7.5 A | 250mg/ml | 218.3mg/ml | -12.7% | 99.31% | 32vpnd | Lab A | Community |
| 17 Nov 2025 | BPC157 10mg + TB500 10mg Blend | 6.9 A | 5mg | 5.7mg | +14.6% | 95.49% | 1cu380 | Lab E | Public |
| 17 Nov 2025 | PE 22-28 | 6.6 A | 20mg | 19.4mg | -3.1% | 97.37% | sax7kw | Lab E | Public |
| 14 Nov 2025 | Chonluten | 5.3 B | 5mg | 6.0mg | +19.8% | 96.47% | waq2gn | Lab B | Public |
| 14 Nov 2025 | PE 22-28 | 6.9 A | 30mg | 35.2mg | +17.2% | 97.89% | 7qqcd6 | Lab G | Community |
| 14 Nov 2025 | Selank 10mg + Semax 10mg Blend | 6.0 A | 2mg | 2.4mg | +20.2% | 98.88% | x1ao0g | Lab B | Public |
| 5 Nov 2025 | Ivermectin | 5.9 B | 20mg | 19.6mg | -2.1% | 99.72% | swlh68 | Lab E | Public |
| 5 Nov 2025 | SR9009 | 7.8 A | 25mg | 24.1mg | -3.7% | 95.39% | 6xxmxe | Lab F | Public |
| 17 Oct 2025 | Selank 10mg + Semax 10mg Blend | 4.0 C | 2mg | 2.5mg | +24.5% | 99.11% | yz5wfu | Lab F | Public |
| 17 Oct 2025 | Tirzepatide Oral | 4.6 C | 20mg | 18.4mg | -8.2% | 95.01% | kmka2h | Lab A | Public |
| 9 Oct 2025 | MT-1 | 7.4 A | 10mg | 9.6mg | -4.4% | 96.78% | 8i4op6 | Lab G | Public |
| 9 Oct 2025 | RAD140 | 4.7 C | 20mg | 21.6mg | +8.1% | 96.10% | oavtsb | Lab B | Public |
| 3 Oct 2025 | Dianabol Raw | 9.3 A | 10g | 12.1g | +21.4% | 97.62% | nb40cb | Lab E | Community |
— END OF EVIDENCE LOG —